Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -
Please visit our MS learning channel on YouTube, which provides hundreds of MS videos presented by MS Experts across the USA, from many of our recorded education programs. Archived here: www.youtube.com/msviewsandnews -- Additionally, please visit our Social media platforms: Facebook, Twitter, and Instagram
Important Resources for the MS community are found on the left side of this blog.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Friday, April 8, 2016
Thursday, April 7, 2016
A patient developed a cerebral Nocardia infection while taking the immunosuppressive agent alemtuzumab (Lemtrada) for relapsing-remitting multiple sclerosis, adding to a list of opportunistic infections seen with the drug, researchers said.
The woman, in her late 40s, developed the infection 5 months after an initial course of alemtuzumab. Her history of anorexia may have contributed to the problem, Thomas Korn, MD, of Technische Universitat Munchen in Germany, and colleagues reported online in JAMA Neurology.